Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

A protein called CBP is found in prostate cancer and can increase the effectiveness of certain prostate cancer treatments.

Androgens are important for normal ovarian function and estrogen production, but may not be the main cause of follicle death.

Some skin conditions may indicate metabolic syndrome, which could help with early detection and management of related health issues.

Early balding men may have insulin resistance, but lifestyle changes can help.

Women with PCOS are more likely to have fatty liver disease and worse metabolic health.

Testosterone and DHEA can benefit women's health but must be prescribed carefully due to potential risks.

ARL15 is important for fat cell development and the release of the hormone adiponectin.

Testosterone therapy helped 63% of androgen-deficient women grow scalp hair, but more research is needed.

Greek women with PCOS have a higher risk of metabolic syndrome and are more likely to be overweight compared to healthy controls.

New treatments for prostate cancer are less toxic and show promise, but more research is needed to enhance their effectiveness and reduce side effects.

Women with greater androgen sensitivity respond better to finasteride for hair loss.

Androgens and SARMs play a role in body mass, frailty, skin health, and hair growth, and are used in treating prostate cancer, acne, and hair loss, with potential for new uses and improved versions in the future.

Finasteride side effects in young men may be linked to specific gene variations.

Rare adrenal cancers that secrete androgens or estrogens have a poor prognosis and are treated primarily with surgery.

Diabetes can lead to blindness and skin problems, and managing blood sugar and blood pressure is crucial to prevent these complications.

Clascoterone is a new, effective, and safe acne treatment without systemic side effects.

Greek women with classic PCOS are more likely to have metabolic syndrome and insulin resistance than those with newer PCOS types.

COVID-19 may worsen with androgens; anti-androgen drugs could help.

Androgen measurements are mostly unnecessary for diagnosing PCOS, except in women with menstrual issues.

Birth control pills increase certain receptor activities in female gerbil prostate glands and can lead to prostate changes.

Hair loss may signal metabolic problems and increased risk of heart disease, suggesting people with hair loss should be checked for these issues.

The mouse models are effective for testing new hair loss treatments.

A postmenopausal woman's facial redness, acne, and excess hair were caused by too much hormone therapy for insomnia, but improved after stopping the treatment.

Free fatty acids may increase androgen production, potentially contributing to polycystic ovary syndrome.

Anagen grow may effectively treat hair loss by blocking testosterone and reducing enzyme activity.

Cyproterone acetate improves skin symptoms and quality of life in women with androgen-related issues.

The conclusion is that adult males with muscle weakness and hormonal imbalances should be tested for Kennedy's disease.

Lower DHT and higher testosterone levels increase brain activation but don't change behavior in heavy drinkers.

Finasteride treatment lowers urine androgen and prostaglandin levels, making them potential markers for effectiveness.

Combining RU58841 and minoxidil significantly increases hair growth.